Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 16 June 2014 | By Alexander Gaffney, RAC,
The European Medicines Agency (EMA) has announced the re-election of Sir Kent Woods as the chair of its influential 35-member Management Board, which sets regulatory policies for the agency.
Woods, who served as chief executive at the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) between 2004 and 2013, will now serve as the board's chair for a final three-year term, after which time term limits preclude him from running again.
Woods said in a statement that he was "proud to lead the Management Board" despite doing so in what he called "turbulent times."
Woods is one of EMA's longest-ever serving members of the management board, EMA said in a statement.
EMA Statement on Kent Woods
Tags: EMA Management Board, Kent Woods, Chair of EMA Management Board, Election